In contrast, the expression of TPM4 was significantly lower than that in normal control tissues in bladder urothelial carcinoma (BLCA), kidney chromophobe (KICH), kidney renal papillary cell carcinoma (KIRP), lung adenocarcinoma (LUAD), skin cutaneous melanoma (SKCM), uterine corpus endometrial carcinoma (UCEC) and uterine carcinosarcoma (UCS) (Fig. 1A). This evidence concerns the gene TPM4 and uterine carcinosarcoma.